ECM
HAE icon

ETrade Capital Management’s Haemonetics HAE Stock Holding History

ETrade Capital Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-20,278
Closed -$801K – 720
2017
Q2 		$801K Sell
20,278
-707
-3% -$29K 0.03% 344
2017
Q1 		$851K Sell
20,985
-1,341
-6% -$52.4K 0.04% 309
2016
Q4 		$898K Sell
22,326
-632
-3% -$23.8K 0.04% 262
2016
Q3 		$832K Buy
+22,958
New +$788K 0.04% 274
2015
Q3 		– Sell
-6,045
Closed -$250K – 419
2015
Q2 		$250K Sell
6,045
-131
-2% -$5.52K 0.01% 380
2015
Q1 		$277K Buy
6,176
+252
+4% +$10.5K 0.02% 349
2014
Q4 		$222K Sell
5,924
-125
-2% -$4.58K 0.01% 422
2014
Q3 		$211K Buy
6,049
+118
+2% +$4.21K 0.01% 415
2014
Q2 		$209K Buy
5,931
+259
+5% +$8.65K 0.01% 407
2014
Q1 		$185K Buy
5,672
+334
+6% +$12.8K 0.01% 320
2013
Q4 		$225K Buy
5,338
+403
+8% +$16.6K 0.02% 268
2013
Q3 		$197K Buy
4,935
+1,104
+29% +$46.3K 0.02% 265
2013
Q2 		$158K Buy
+3,831
New +$155K 0.02% 260

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

ETrade Capital Management's HAE Position: Q3 2017 in Review

ETrade Capital Management sold out of Haemonetics (HAE) in Q3 2017, closing a stake of 20,278 shares — an estimated $801K sold.

ETrade Capital Management first reported a position in HAE in Q2 2013 and held it in 13 quarters. The position peaked at $898K in Q4 2016. 207 funds tracked by Wall St. Rank hold HAE as of Q3 2017.

  • ETrade Capital Management reported no remaining Haemonetics position as of Q3 2017 after selling out during the quarter.
  • ETrade Capital Management sold 20,278 Haemonetics shares in Q3 2017, an estimated $801K.
  • ETrade Capital Management first reported a position in Haemonetics in Q2 2013 and held it in 13 quarters.
  • ETrade Capital Management's Haemonetics position peaked at $898K in Q4 2016.
  • 207 funds tracked by Wall St. Rank held Haemonetics as of Q3 2017.

Based on ETrade Capital Management's 13F filing for Q3 2017, filed 9 Nov 2017.